Clinical trial
Non-inferiority Study for Visual Field Mean Defect Estimation Using Sequentially Optimized Reconstruction Strategy (SORS) With an OCTOPUS 900 Perimeter on Healthy and Glaucoma Subjects
NCT03325751 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-inferiority Study for Visual Field Mean Defect Estimation Using Sequentially Optimized Reconstruction Strategy (SORS) With an OCTOPUS 900 Perimeter on Healthy and Glaucoma Subjects
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2018
- Completion date
- November 1, 2019
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.